3rd August 2026, Monday

TechPharus

Latest Posts

HealthTech News

  • Drug spending increasingly rewards pharmaceutical innovation over ‘me-too’ medicines
    on August 3, 2026 at 8:00 pm

    A long-running debate over prescription drug costs has centered on whether drug manufacturers are better rewarded for truly innovative medicines or so-called “me-too” drugs that may offer only incremental improvements over existing treatments but still command high prices.

  • Emotion regulation therapy may help reduce problem alcohol use
    on August 3, 2026 at 7:40 pm

    A new treatment designed to improve emotional regulation in people with alcohol use disorder may help them drink less often. In a study of people receiving cognitive behavioral therapy (CBT) for alcohol use disorder, those who also received emotion regulation treatment had a greater percentage of nondrinking days. The results, published in Alcohol: Clinical and Experimental Research, suggest that emotion regulation treatment may be a beneficial supplement to cognitive behavioral therapy for people who report drinking heavily in response to negative emotional experiences.

  • Breast milk protein osteopontin may shield infants from respiratory infections
    on August 3, 2026 at 7:40 pm

    QIMR Berghofer researchers have found how breast milk supports infant immunity via a protein called osteopontin. The study also identifies a potential way of mimicking this protective effect in baby formula. The findings, published today in the journal Cell, reveal osteopontin triggers a cascade of biological signals that support immune cell development in a baby’s liver and lungs and help protect against potentially deadly respiratory infections.

  • Rare chromosomal differences found in children with fetal alcohol spectrum disorder
    on August 3, 2026 at 7:20 pm

    One in four children diagnosed with fetal alcohol spectrum disorder was found to have rare chromosomal differences at considerably higher rates than the general population, according to a study published in Alcohol: Clinical and Experimental Research. Half of those differences were associated with harmful or potentially harmful genetic variations. The study’s authors recommend high-resolution genetic testing whenever fetal alcohol spectrum disorder is diagnosed to provide a more complete clinical diagnosis and identify opportunities for improved medical management.

  • Rare bone disease often goes untreated while patients quietly live with chronic pain
    on August 3, 2026 at 7:20 pm

    Teeth and bones are among the hardest structures in the human body, but certain inherited conditions can rob them of that strength. One of them is hypophosphatasia (HPP), a rare, lifelong genetic bone disorder that disrupts the development of bones and teeth, leaving them unusually soft and fragile. A recent study set out to determine how common HPP is across Central and Eastern Europe and how it presents in patients.